Skip to main content
. 2011 Feb 11;13(1):R21. doi: 10.1186/ar3245

Figure 4.

Figure 4

A longitudinal study of RA patients receiving tocilizumab. A) DAS28 B) CRP values, C) ESR values and D) relative K2P5.1 expression levels are compared for patients with therapy switch to tocilizumab over six months. Note that the y-axis in D) is split for better clarity and that two patients are marked in red.